As of the latest Form 4 filed Jul 9, 2026.
What Spruce Biosciences, Inc. Common Stock insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 12 most recent filings for SPRB.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-09 | 2026-06-30 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | AAward | +266.00 | $4.53 | $1.21K | No | Form 4 ↗ |
| 2026-01-21 | 2025-12-11 | Ways Douglas Kirk Interim Chief Medical Officer | MExercise | +1.25K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2025-10-22 | 2025-10-20 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | FTax | −1.54K | $148.16 | $228K | No | Form 4 ↗ |
| 2025-10-22 | 2025-10-20 | Szwarcberg Javier B., CHIEF EXECUTIVE OFFICER | MExercise | +4.78K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2025-10-22 | 2025-10-20 | Gharib Samir M. PRESIDENT AND CFO | FTax | −661.00 | $148.16 | $97.9K | No | Form 4 ↗ |
| 2025-10-22 | 2025-10-20 | Gharib Samir M., PRESIDENT AND CFO | MExercise | +2.05K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2025-10-15 | 2025-10-06 | Parkman Healthcare Partners LLC 10% owner | SSale | −25.00 | $17.46 | $436.39 | No | Form 4 ↗ |
| 2025-10-15 | 2025-10-06 | Parkman Healthcare Partners LLC, 10% owner | SSale | −232.00 | $19.33 | $4.48K | No | Form 4 ↗ |
| 2025-10-15 | 2025-10-06 | Parkman Healthcare Partners LLC, 10% owner | PPurchase | +256.00 | $17.91 | $4.59K | No | Form 4 ↗ |
| 2025-10-08 | 2025-10-06 | Parkman Healthcare Partners LLC 10% owner | SSale | −25.00 | $17.46 | $436.39 | No | Form 4 ↗ |
| 2025-10-08 | 2025-10-06 | Parkman Healthcare Partners LLC, 10% owner | SSale | −232.00 | $19.33 | $4.48K | No | Form 4 ↗ |
| 2025-10-08 | 2025-10-06 | Parkman Healthcare Partners LLC, 10% owner | PPurchase | +256.00 | $17.91 | $4.59K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also SPRB’s full analysis or the market-wide insider trading feed. The tabs above jump to SPRB’s other SEC data.
Source: SEC Form 4 filings for SPRB, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.